about
The Adenosinergic System in Diabetic RetinopathyContribution of microglia-mediated neuroinflammation to retinal degenerative diseasesTherapeutic Opportunities for Caffeine and A2A Receptor Antagonists in Retinal DiseasesEffects of 3,4-methylenedioxymethamphetamine administration on retinal physiology in the ratNPY in rat retina is present in neurons, in endothelial cells and also in microglial and Müller cellsDiabetes alters KIF1A and KIF5B motor proteins in the hippocampusContribution of TNF receptor 1 to retinal neural cell death induced by elevated glucoseCalcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetesHeme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity.Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspase-independent pathway.Long-term exposure to high glucose induces changes in the content and distribution of some exocytotic proteins in cultured hippocampal neurons.Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeabilityNitric oxide modulates sodium vitamin C transporter 2 (SVCT-2) protein expression via protein kinase G (PKG) and nuclear factor-κB (NF-κB).Diabetic hyperglycemia reduces Ca2+ permeability of extrasynaptic AMPA receptors in AII amacrine cells.Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma.Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells.Protective Effect of a GLP-1 Analog on Ischemia-Reperfusion Induced Blood-Retinal Barrier Breakdown and InflammationNeuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate.Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to neuroprotection.Regulation of claudins in blood-tissue barriers under physiological and pathological statesNeuropeptide Y system in the retina: From localization to function.Effects of drugs of abuse on the central neuropeptide Y system.Glia-Mediated Retinal Neuroinflammation as a Biomarker in Alzheimer's Disease.Inside the Diabetic Brain: Role of Different Players Involved in Cognitive Decline.Opening eyes to nanomedicine: Where we are, challenges and expectations on nanotherapy for diabetic retinopathy.Obesity and brain inflammation: a focus on multiple sclerosis.Viewing the choroid: where we stand, challenges and contradictions in diabetic retinopathy and diabetic macular oedema.c-Src function is necessary and sufficient for triggering microglial cell activation.Modeling Human Glaucoma: Lessons from the in vitro Models.Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.Sildenafil Acutely Decreases Visual Responses in ON and OFF Retinal Ganglion Cells.Müller cells do not influence leukocyte adhesion to retinal endothelial cells.Diabetes causes transient changes in the composition and phosphorylation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and interaction with auxiliary proteins in the rat retina.Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors trigger neuronal nitric-oxide synthase activation to promote nerve cell death in an Src kinase-dependent fashion.Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro.Elevated Glucose and Interleukin-1β Differentially Affect Retinal Microglial Cell Proliferation.Diabetes changes the levels of ionotropic glutamate receptors in the rat retina.Evaluation of neurotoxic and neuroprotective pathways affected by antiepileptic drugs in cultured hippocampal neurons.
P50
Q26748944-144F8127-7E46-45CE-A33D-89A5354ADCC8Q27007111-DA3A3DCF-2768-43FF-822C-19243AC947BFQ28066887-7CE710CC-5B38-48D3-831A-D1584C06F612Q28478597-C9437DB1-18AD-4E55-9B64-638860FEED5DQ28565719-21666058-9F84-42D3-870F-2314414F5DE1Q28567468-72F18898-AE3B-45C8-9F7C-F9960914CB3EQ28579243-4199FF70-022A-42DD-878F-ACE97BFB6234Q28584295-A2F1CAE2-78CA-4086-BE8E-8ACA0C5CEBC5Q31083347-A400910C-0528-46C5-8D84-14CA5FADA62EQ33303988-BF61B55D-1AC4-4BDD-85B5-1D4F5BEDC7FBQ33400153-54D8512C-C2CA-4FE6-8BB0-294A6A2B8087Q33720065-A139BE9D-AFA6-41C6-825F-4BD26CB44D17Q34014053-B8D34470-DDCA-464A-8500-F494176F4558Q34237700-F954AB66-AC91-4DED-81BC-9AB73184B5ADQ35763283-7D323174-B313-455D-8D87-73FE7503A24EQ36032969-9506FE85-7D0E-4876-86CA-686579E9B5D9Q36043139-CCAA789B-B55C-425B-9394-B6EC7B9A4914Q36536592-C833176F-0C6E-4C6C-A9DE-E831C8E1A874Q36904161-484F7732-16D4-4684-9F30-78A7BB8853A7Q36907135-0443389B-8CDD-4F6E-99D5-D0B4BCF571EAQ38159249-5EB83065-5246-4372-BF5A-7BCAC85E288AQ38199105-CD9C60AF-FD77-47F2-B898-4771AA807A64Q38386788-919C6A22-1795-4CA0-B4E6-E60C1D986A93Q38436912-BC944CD6-E162-4527-A2B3-A0B8BCF8DF7EQ38620502-DE9D528C-7627-4BF4-82E9-AFBF7053D101Q38669413-25F32843-EA79-4B54-8E0D-16B26CD595BDQ38692535-787B2036-E2FA-4742-BC8E-444D716BC25AQ38702348-FEF29313-E2F1-4F33-9D03-8C1BB1B4782EQ38829399-6AC08912-78BF-4883-B46B-1C26952E271AQ38938038-8B5D0B35-E119-49AF-A21A-8444E39B4D0FQ38951968-153D43A1-1FE3-4318-B9D7-F3AFF589C855Q39157059-B54960FE-E34F-43A8-8141-817F68AB8D12Q39219917-581A9028-4EE6-4C91-9710-19CCD54F2887Q39948735-F57AADEF-EF21-4302-897B-35B24A1A4280Q41021679-4FEDF33D-A3FC-4AEB-B243-B1DA7B9CA0B9Q41311919-6A4ED958-EEB3-4D87-9D9E-931032817EE5Q41863270-B3A2ECB5-EA6F-43B7-B27D-38E04E667A1EQ41881865-95B105BE-E580-4CC6-8981-77F9C6769B28Q42115030-E2A9C8EC-5C76-45E3-B3D8-FE5ECA4ED28AQ42445199-D18F3517-D136-4B4D-858A-6568F4E7EDFD
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
António Francisco Ambrósio
@ast
António Francisco Ambrósio
@en
António Francisco Ambrósio
@es
António Francisco Ambrósio
@nl
type
label
António Francisco Ambrósio
@ast
António Francisco Ambrósio
@en
António Francisco Ambrósio
@es
António Francisco Ambrósio
@nl
prefLabel
António Francisco Ambrósio
@ast
António Francisco Ambrósio
@en
António Francisco Ambrósio
@es
António Francisco Ambrósio
@nl
P106
P1153
7006302528
P21
P31
P496
0000-0002-0477-1641